Cagrilintide 5mg + Semaglutide 5mg Blend
extensively-studiedResearch blend of Cagrilintide and Semaglutide. RaysunPeptide manufactures and supplies Cagrilintide 5mg + Semaglutide 5mg Blend for qualified research, laboratory, and B2B applications.
This product is a research blend combining Cagrilintide (5mg) and Semaglutide (5mg). Cagrilintide is an amylin analog, while Semaglutide is a GLP-1 receptor agonist. Both peptides have been studied individually in metabolic research. This combination is provided for comparative laboratory research. RaysunPeptide supplies this blend for qualified research and laboratory applications only.
Mechanism of Action
Dual amylin/GLP-1 receptor agonism for enhanced satiety and metabolic regulation.
Molecular Data
Side Effects & Safety
FAQs
What is Cagrilintide 5mg + Semaglutide 5mg Blend?
Research blend of Cagrilintide and Semaglutide. It has been studied in preclinical and laboratory research settings.
Does RaysunPeptide provide COA for Cagrilintide 5mg + Semaglutide 5mg Blend?
Yes, a Certificate of Analysis is available upon request for each batch.
What specifications are available?
Cagrilintide 5mg + Semaglutide 5mg Blend is available in 10mg configurations.
